VolitionRx Limited Interest Expense
VolitionRx Limited (VNRX) reported Interest Expense of $41.03 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2022-05-11
- VolitionRx Limited interest expense for the quarter ending 2022-03-31 was $41.03K, a 2.72% decline year-over-year.
- VolitionRx Limited interest expense for the quarter ending 2021-12-31 was $35.17K, a 9.12% decline year-over-year.
- VolitionRx Limited interest expense for the quarter ending 2021-09-30 was $38.77K, a 11.65% increase year-over-year.
- VolitionRx Limited interest expense for the quarter ending 2021-06-30 was $39.69K, a 75.58% increase year-over-year.
- VolitionRx Limited interest expense for fiscal 2021 was $155.80K, a 20.03% increase from fiscal 2020.
- VolitionRx Limited interest expense for fiscal 2020 was $129.80K, a 2.55% increase from fiscal 2019.
- VolitionRx Limited interest expense for fiscal 2019 was $126.57K.
- VolitionRx Limited interest expense for fiscal 2018 was -$110.92K, a 251.67% decline from fiscal 2017.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | $41.03K 10-Q · filed 2022-05-11 | $76.20K derived: sum of 2 quarters · filed 2022-05-11 | $114.97K derived: sum of 3 quarters · filed 2022-05-11 | $154.65K derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2021-12-31 | $35.17K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $73.93K derived: sum of 2 quarters · filed 2022-03-30 | $113.62K derived: sum of 3 quarters · filed 2022-03-30 | $155.80K 10-K · filed 2022-03-30 | |||
| 2021-09-30 | $38.77K 10-Q · filed 2021-11-10 | $78.45K derived: sum of 2 quarters · filed 2021-11-10 | $120.64K 10-Q · filed 2021-11-10 | $159.33K derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2021-06-30 | $39.69K 10-Q · filed 2021-08-11 | $81.87K 10-Q · filed 2021-08-11 | $120.56K derived: sum of 3 quarters · filed 2022-05-11 | $155.28K derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2021-03-31 | $42.18K 10-Q · filed 2022-05-11 | $80.88K derived: sum of 2 quarters · filed 2022-05-11 | $115.60K derived: sum of 3 quarters · filed 2022-05-11 | $138.20K derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2020-12-31 | $38.69K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $73.42K derived: sum of 2 quarters · filed 2022-03-30 | $96.02K derived: sum of 3 quarters · filed 2022-03-30 | $129.80K 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $34.72K 10-Q · filed 2021-11-10 | $57.33K derived: sum of 2 quarters · filed 2021-11-10 | $91.11K 10-Q · filed 2021-11-10 | $122.17K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $22.60K 10-Q · filed 2021-08-11 | $56.38K 10-Q · filed 2021-08-11 | $87.45K derived: sum of 3 quarters · filed 2021-08-11 | $119.74K derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | $33.78K 10-Q · filed 2021-05-11 | -$33.78K 10-Q · filed 2020-05-07 | $64.84K derived: sum of 2 quarters · filed 2021-05-11 | $97.14K derived: sum of 3 quarters · filed 2021-05-11 | $130.25K derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $31.07K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $63.36K derived: sum of 2 quarters · filed 2021-03-22 | $96.47K derived: sum of 3 quarters · filed 2021-03-22 | $126.57K 10-K · filed 2021-03-22 | -$126.57K 10-K · filed 2020-02-20 | ||
| 2019-09-30 | $32.29K 10-Q · filed 2020-11-12 | -$32.29K 10-Q · filed 2019-11-12 | $65.41K derived: sum of 2 quarters · filed 2020-11-12 | $95.51K 10-Q · filed 2020-11-12 | -$95.51K 10-Q · filed 2019-11-12 | $3.03K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $33.12K 10-Q · filed 2020-08-13 | $63.22K 10-Q · filed 2020-08-13 | -$29.26K derived: sum of 3 quarters · filed 2020-08-13 | -$58.37K derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | -$30.10K 10-Q · filed 2020-05-07 | $30.10K 10-Q · filed 2019-05-08 | -$62.38K derived: sum of 2 quarters · filed 2020-05-07 | -$91.49K derived: sum of 3 quarters · filed 2020-05-07 | -$64.93K derived: sum of 4 quarters · filed 2020-05-07 | ||
| 2018-12-31 | -$32.28K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$61.39K derived: sum of 2 quarters · filed 2020-02-20 | -$34.83K derived: sum of 3 quarters · filed 2020-02-20 | -$110.92K 10-K · filed 2020-02-20 | $110.92K 10-K · filed 2019-03-13 | ||
| 2018-09-30 | -$29.11K 10-Q · filed 2019-11-12 | $29.11K 10-Q · filed 2018-11-07 | -$2.55K derived: sum of 2 quarters · filed 2019-11-12 | -$78.65K 10-Q · filed 2019-11-12 | $78.65K 10-Q · filed 2018-11-07 | $43.30K derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $26.56K 10-Q · filed 2019-08-12 | $49.54K 10-Q · filed 2019-08-12 | $72.41K derived: sum of 3 quarters · filed 2019-08-12 | $90.03K derived: sum of 4 quarters · filed 2019-08-12 | |||
| 2018-03-31 | $22.98K 10-Q · filed 2019-05-08 | $45.86K derived: sum of 2 quarters · filed 2019-05-08 | $63.48K derived: sum of 3 quarters · filed 2019-05-08 | $83.91K derived: sum of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | $22.87K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $40.49K derived: sum of 2 quarters · filed 2019-03-13 | $60.93K derived: sum of 3 quarters · filed 2019-03-13 | $73.13K 10-K · filed 2019-03-13 | |||
| 2017-09-30 | $17.62K 10-Q · filed 2018-11-07 | $38.05K derived: sum of 2 quarters · filed 2018-11-07 | $50.26K 10-Q · filed 2018-11-07 | ||||
| 2017-06-30 | $20.43K 10-Q · filed 2018-08-13 | $32.64K 10-Q · filed 2018-08-13 | |||||
| 2017-03-31 | $12.21K 10-Q · filed 2018-05-10 | ||||||
| 2016-12-31 | $20.38K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |